Misclassification of Recent HIV-1 Seroconversion in Sub-Saharan Africa
Author Information
Author(s): Duedu Kwabena O, Hayford Anna A, Sagoe Kwamena W
Primary Institution: University of Ghana Medical School
Hypothesis
What are the reasons for reported misclassifications of recent HIV-1 seroconversion in sub-Saharan Africa?
Conclusion
The modified Determine HIV-1/2 S/LS assay, when used with confirmation of HIV-1 seropositivity, is a rapid and cost-effective method for determining recent HIV-1 infections in resource-limited settings.
Supporting Evidence
- The study confirmed that misclassifications of recent HIV-1 seroconversion were prevalent in sub-Saharan Africa.
- Only one of the 23 samples classified as recent seroconversions was confirmed as seropositive for HIV-1.
- The modified Determine S/LS assay was found to be a simpler and less costly method for detecting recent HIV-1 infections.
Takeaway
This study found that a common test for recent HIV infections often gives wrong results in Africa, but a better method can help find the right cases.
Methodology
The study used the modified Determine HIV-1/2 sensitive/less sensitive method and confirmed results with a line immunoassay.
Potential Biases
There is a risk of overestimating recent HIV seroconversion due to misclassifications.
Limitations
The study was limited by the absence of clinical information on blood donor samples and the potential for misclassification of recent infections.
Participant Demographics
Blood donor plasma samples from Ghana.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website